Cash & equivalents increased 41.8%
Cash & equivalents changed +41.8% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +41.8% from the comparable as-filed period.
Gross profit changed +31.9% from the comparable as-filed period.
Net income changed +73.8% from the comparable as-filed period.
Operating income changed +104.9% from the comparable as-filed period.
Operating margin changed +336 basis points from the comparable as-filed period.
Revenue changed +28.8% from the comparable as-filed period.
Stock-based compensation changed +27.6% from the comparable as-filed period.
Gross margin changed +62 basis points from the comparable as-filed period.
Research & development changed +0.6% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.